Bortezomib (PS-341) treatment decreases inflammation and partially rescues the expression of the dystrophin-glycoprotein complex in GRMD dogs. [electronic resource]
Producer: 20131022Description: e61367 p. digitalISSN:- 1932-6203
- Animals
- Boronic Acids -- administration & dosage
- Bortezomib
- Chymotrypsin -- metabolism
- Collagen -- metabolism
- Dogs
- Dystroglycans -- metabolism
- Dystrophin-Associated Protein Complex -- metabolism
- Gene Expression
- Immunohistochemistry
- Inflammation -- drug therapy
- Muscle, Skeletal -- metabolism
- Muscular Dystrophy, Animal -- diagnosis
- Muscular Dystrophy, Duchenne -- diagnosis
- Proteasome Endopeptidase Complex -- metabolism
- Pyrazines -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.